로딩 중…
지수 로딩 중…
Nektar Therapeutics
NKTR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$60.98+0.10%
2026-06-18
Price Chart
Nektar Therapeutics+608.25%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.06B |
| Revenue | $56M |
| Net Income | $-158M |
| Total Assets | $763M |
| Net Assets | $576M |
| Value | |
| P/B | 3.58x |
| P/S | 37.03x |
| FCF Yield | -9.90% |
| Profitability | |
| ROE | -27.44% |
| ROA | -20.71% |
| Op. Margin | -224.88% |
| Revenue Growth | 3.83% |
| Financial Health | |
| Debt Ratio | 32.46% |
| Total Debt | $143M |
| FCF | $-204M |
| Cash | $132M |
| Current Ratio | 10.21x |
| Performance | |
| 1Y Return | 608.25% |
| 1M Return | -9.77% |
| From 52W High | -44.05% |
| 1Y MDD | -46.54% |
| Trading | |
| Volume | 807,898 shares |
| Trading Value | $49M |
| Per Share | |
| EPS | $-8.08 |
| BPS | $4.43 |